8-K: Mosaic Q2 2025 Earnings Soar, Potash Outlook Raised

The Mosaic Company reported a significant increase in Q2 2025 net income to $411 million, driven by higher prices and efficiency gains, while raising its full-year potash production guidance.

Summary

• Net income for the second quarter of 2025 increased to $411 million, compared to a net loss of $162 million in the same quarter of the prior year.
• Diluted earnings per share (EPS) for Q2 2025 was $1.29, up from $(0.50) in Q2 2024.
• Adjusted EBITDA for Q2 2025 was $566 million, a decrease from $584 million in Q2 2024, reflecting a $130 million impact from larger-than-usual provisions ($64 million) and higher idle and turnaround expenses ($66 million).
• Notable items positively impacted Q2 2025 net income by $339 million pre-tax, primarily due to $220 million in unrealized foreign currency gains and a $216 million mark-to-market unrealized gain on Ma'aden shares.
• Mosaic Fertilizantes segment reported operating income of $109 million and adjusted EBITDA of $159 million.
• The $150 million cost reduction program was achieved, with $106 million realized within the Mosaic Fertilizantes segment and $55 million from SG&A, and is now expanded to $250 million to be achieved by the end of 2026.
• Full-year 2025 potash production volume guidance was raised to 9.3 to 9.5 million tonnes.
• The Palmeirante blending facility and Esterhazy Hydrofloat project were completed in July 2025, with Hydrofloat adding an additional 400,000 tonnes of annual potash capacity.
• Selling, general and administrative (SG&A) expenses increased to $167 million in Q2 2025 from $128 million in Q2 2024, mainly due to $33 million in bad debt provisions ($30 million from a single customer) and $7 million in non-cash amortization.
• Cash flow from operations was $610 million in Q2 2025, down from $847 million in Q2 2024, primarily due to lower customer prepayments and higher working capital.
• Free cash flow in Q2 2025 was $305 million, compared to $513 million in Q2 2024.
• Paid a $0.22 per share dividend in Q2 2025, totaling $70 million returned to shareholders.
• Phosphate sales volumes declined from 1.7 million tonnes in Q2 2024 to 1.5 million tonnes in Q2 2025, driven by production downtime for maintenance.
• Phosphate cash cost of conversion per tonne was $126 in Q2 2025, up from $100 in Q2 2024, but improved from $134 in Q1 2025.
• MOP cash cost of production per tonne for Potash was $75 in Q2 2025, up from $64 in Q2 2024.
• Mosaic Biosciences product sales grew over 100% in the first half of 2025 compared to the first half of 2024, on track to more than double to about $70 million in 2025, and are expected to positively contribute to adjusted EBITDA in Q4.

Sentiment

Score: 8

Explanation: The company reported a significant turnaround in net income and EPS, driven by strong market prices and strategic initiatives. The achievement and expansion of cost reduction programs, coupled with raised potash production guidance and successful project completions, indicate strong operational execution and a positive outlook for the second half of the year. While there were impacts from provisions and higher turnaround expenses, and some cash flow metrics were down year-over-year due to working capital, the overall narrative is one of robust recovery and strategic growth.

Positives

• Net income significantly increased to $411 million in Q2 2025 from a loss of $162 million in Q2 2024, reflecting a strong financial turnaround.
• Diluted EPS rose to $1.29 in Q2 2025 from $(0.50) in Q2 2024.
• Higher average selling prices across all segments contributed to improved results, reflecting strong market dynamics.
• Cost efficiencies in the Mosaic Fertilizantes segment contributed to its strong performance.
• Notable items provided a positive pre-tax impact of $339 million, including $220 million in unrealized foreign currency gains and a $216 million mark-to-market gain on Ma'aden shares.
• Mosaic Fertilizantes operating income increased to $109 million from $61 million (Q2 2024), and Adjusted EBITDA to $159 million from $96 million (Q2 2024).
• The $150 million cost reduction program was successfully achieved, with $106 million from Mosaic Fertilizantes and $55 million from SG&A.
• The value capture program target was expanded to $250 million to be achieved by the end of 2026, indicating further efficiency potential.
• Full-year 2025 potash production volume guidance was raised to 9.3-9.5 million tonnes, capitalizing on strengthening market conditions.
• Completion of the Palmeirante blending facility and Esterhazy Hydrofloat in July 2025, with Hydrofloat adding 400,000 tonnes of annual potash capacity, is expected to drive future production cost per tonne lower.
• MOP cash cost of production per tonne decreased sequentially to $75 in Q2 2025 from $78 in Q1 2025.
• Phosphate cash cost of U.S. mined rock decreased to $51 per tonne in Q2 2025 from $54 in Q2 2024.
• Phosphate cash cost of conversion per tonne improved sequentially to $126 in Q2 2025 from $134 in Q1 2025.
• Mosaic Fertilizantes Phosphate cash cost of conversion per tonne declined to $84 in Q2 2025 from $87 in Q1 2025.
• Mosaic Fertilizantes Potash cash production cost per tonne decreased to $178 in Q2 2025 from $187 in Q1 2025.
• Mosaic Biosciences product sales grew over 100% in H1 2025 vs. H1 2024, on track to double to $70 million in 2025, and are expected to positively contribute to adjusted EBITDA in Q4.
• Strong global phosphate demand and improved production output levels are expected for Q3 2025.
• Global potash demand remains healthy, with a potential global shipments record expected this year.
• Optimistic outlook for fertilizer markets through the remainder of 2025, driven by balanced to tight supply and continued strong demand pull.

Negatives

• Adjusted EBITDA decreased to $566 million in Q2 2025 from $584 million in Q2 2024.
• Adjusted EBITDA was negatively impacted by $130 million from larger-than-usual provisions ($64 million) and higher idle and turnaround expenses ($66 million).
• Selling, general and administrative (SG&A) expenses increased to $167 million in Q2 2025 from $128 million in Q2 2024, primarily due to $33 million in bad debt provisions, of which $30 million is from a single customer.
• Cash flow from operations decreased to $610 million in Q2 2025 from $847 million in Q2 2024, driven by lower customer prepayments and higher working capital.
• Free cash flow decreased to $305 million in Q2 2025 from $513 million in Q2 2024.
• Phosphate operating earnings were a loss of $(8) million in Q2 2025, a significant decline from $133 million in Q2 2024.
• Phosphate sales volumes declined from 1.7 million tonnes in Q2 2024 to 1.5 million tonnes in Q2 2025 due to production downtime.
• Phosphate cash cost of conversion per tonne increased to $126 in Q2 2025 from $100 in Q2 2024.
• Potash MOP cash cost of production per tonne increased to $75 in Q2 2025 from $64 in Q2 2024.
• Revised 2025 MOP cash cost of production per tonne target to a range of $70-$75 from $64-$69, due to increased participation of higher-cost Colonsay production and the strengthening Canadian dollar.
• Mosaic Fertilizantes distribution margin per tonne was in the mid-$20s in Q2 2025, below the normalized range of $30-$40 per tonne, due to shipment deferrals.
• Full-year Mosaic Fertilizantes sales volumes are now expected to be at the low end of the 10.0-10.8 million tonne guidance range due to challenging credit environment in Brazil.
• Global trade uncertainty and anticipation of large harvests have pressured corn and soybean markets, negatively impacting nutrient affordability.

Risks

• Political and economic instability and changes in government policies in countries where operations are located.
• Predictability and volatility of, and customer expectations about, agriculture, fertilizer, raw material, energy, and transportation markets, which are subject to competitive and other pressures and economic and credit market conditions.
• The level of inventories in the distribution channels for crop nutrients.
• The effect of future product innovations or development of new technologies on demand for products.
• Changes in foreign currency and exchange rates, which can impact financial results.
• International trade risks, including the impact of U.S. tariffs and retaliatory tariffs on economic conditions, and other risks associated with international operations.
• A material adverse change in the Ma'aden investment with respect to its financial position, performance, operations, or prospects.
• Customer defaults, as evidenced by recent bad debt provisions.
• The effects of decisions to exit business operations or locations.
• Changes in government policy.
• Changes in environmental and other governmental regulation, including expansion of regulated water resources, carbon taxes, greenhouse gas regulation, and nutrient discharge standards.
• Further developments in judicial or administrative proceedings, or complaints that operations are adversely impacting nearby farms, business operations, or properties.
• Difficulties or delays in receiving, increased costs of, or challenges to necessary governmental permits or approvals, or increased financial assurance requirements.
• Resolution of global tax audit activity.
• The effectiveness of processes for managing strategic priorities.
• Adverse weather conditions affecting operations in Central Florida, the Mississippi River basin, the Gulf Coast of the United States, Canada, or Brazil, including potential hurricanes, excess heat, cold, snow, rainfall, or drought.
• Actual costs of various items differing from management's current estimates, including asset retirement, environmental remediation, reclamation, Canadian resources taxes, and royalties.
• Reduction of available cash and liquidity, and increased leverage, due to the use of cash and/or available debt capacity to fund financial assurance requirements and strategic investments.
• Brine inflows at potash mines.
• Other accidents and disruptions involving operations, including potential mine fires, floods, explosions, seismic events, sinkholes, or releases of hazardous or volatile chemicals.
• Risks associated with cybersecurity, including reputational loss.

Future Outlook

Management expects third quarter adjusted EBITDA to grow to over $200 million, driven by peak seasonal volumes and distribution margins. Third quarter phosphate sales volumes are anticipated to be 1.8 to 2.0 million tonnes, with DAP prices averaging $700 to $720 per tonne. Potash sales volumes for Q3 are expected to be between 2.2 and 2.4 million tonnes, with MOP prices in the range of $270 to $290 per tonne. The full-year 2025 potash production volume guidance has been raised to 9.3 to 9.5 million tonnes. Cash flow from operations is expected to be stronger in the second half of 2025 compared to the first half, and significant free cash flow is anticipated through the balance of the year. The 2025 capital expenditure outlook remains unchanged at $1.2-$1.3 billion. The Patos de Minas transaction is on track to close by the end of 2025, and negotiations for the Arax and Patrocnio Niobium project are expected to resume in the first half of 2026 after further feasibility studies. Phosphate operations are expected to run at an 8 million tonne annual run rate from August through the rest of the year, with 2025 production volumes in the 6.9 to 7.2 million tonnes range. Cash cost of conversion per tonne for phosphate is expected to decline for the remainder of the year, ending in the range of $95-$100 per tonne. Mosaic Biosciences sales are on track to more than double to about $70 million in 2025 and are expected to positively contribute to adjusted EBITDA in the fourth quarter. The company is optimistic about fertilizer markets through the remainder of 2025, driven by balanced to tight supply and continued strong demand pull, with any demand deferral setting the stage for strong demand in 2026.

Management Comments

• "Mosaic's second quarter 2025 performance reflects extensive maintenance activity and several discreet items."
• "The work we completed in the first six months of the year sets the stage for a strong second half, supported by improved operating performance, reduced turnaround activity, our excellent execution in Brazil, and compelling fertilizer market fundamentals."
• "We expect to generate significant free cash flow through the balance of the year."

Industry Context

Global trade uncertainty and anticipation of large harvests have pressured corn and soybean markets, negatively impacting nutrient affordability. However, grower economics remain constructive across much of the world, incentivizing nutrient replenishment and maximizing yields. New biofuel legislation is expected to provide key support to grains and oilseeds, driving continued demand growth for U.S. production and input demand. Fertilizer markets continued to tighten through the first half of the year due to limited new phosphate supply combined with healthy demand. Strong potash demand outpaced producers' ability to sufficiently boost supply, leading to price increases for both phosphate and potash. North American phosphate inventories remained low heading into summer fill, with summer pricing higher than prevailing spring values. Tariffs on most phosphate import sources are keeping arrivals below last year. Chinese DAP/MAP exports were down 50% year-over-year in the first half, and another annual decline is expected due to domestic demand and lithium-iron-phosphate growth. Indian phosphate inventories are extremely low, encouraging import purchases despite high prices. Ammonia prices are expected to move lower as new facilities ramp up, while sulfur prices have stabilized. Global potash demand remains healthy, with a potential record for global shipments this year, as production in Belarus and Russia is constrained and Laos expansions face challenges.

Comparison to Industry Standards

• Global potash demand remains healthy, and a global shipments record could be set again this year, indicating strong market conditions that Mosaic is capitalizing on.
• Production has been constrained in Belarus and Russia due to maintenance activities while expansions in Laos continue to face significant challenges, positioning Mosaic favorably to meet global demand.
• Chinese DAP/MAP exports through the first half of the year were down by 50% year-over-year, and despite a ramp up in the third quarter, Mosaic expects another annual decline, suggesting a tightening global supply that benefits Mosaic's market position.

Stakeholder Impact

• Shareholders are positively impacted by the significant increase in net income and EPS, the payment of a $0.22 per share dividend, and the positive future outlook driven by strategic achievements and market conditions.
• Customers may benefit from improved product availability due to increased production volumes and new facility capacity, although some in Brazil faced shipment deferrals due to a challenging credit environment.
• Employees in areas with new facility completions (Esterhazy, Palmeirante) and continued operations (Colonsay) may see stable or increased employment opportunities, while the expanded cost reduction program suggests a continued focus on operational efficiency.
• Creditors may note the lower cash flow from operations and free cash flow in Q2 2025 compared to the prior year, but the expectation of stronger cash flow in the second half of 2025 and unchanged capital expenditure outlook provide reassurance.

Next Steps

• Ramp up Esterhazy Hydrofloat to its full 400,000 tonnes of annual capacity.
• Run phosphate operations at an 8 million tonne annual run rate from August through the rest of the year.
• Close the Patos de Minas transaction by the end of 2025.
• Achieve the expanded $250 million value capture program by the end of 2026.
• Resume negotiations for the Arax and Patrocnio Niobium project in the first half of 2026 after further feasibility studies.
• Launch an additional three Mosaic Biosciences products in the second half of 2025.
• Continue to run the Colonsay potash mine until the end of the year to meet stronger demand.
• Conduct a conference call on August 6, 2025, to discuss second quarter 2025 earnings results.

Key Dates

Recommendation

The company delivered a strong financial performance in Q2 2025, reversing a prior-year loss and significantly increasing net income and EPS. Strategic initiatives, such as the achievement and expansion of the cost reduction program, coupled with the successful commissioning of new production capacity (Esterhazy Hydrofloat, Palmeirante blending facility), position the company for continued operational efficiency and growth. The raised full-year potash production guidance and optimistic outlook for fertilizer markets, driven by tight supply and strong demand, suggest robust future earnings potential. While there were some impacts from provisions and working capital, the underlying business fundamentals and management's proactive measures indicate a compelling investment opportunity.

Keywords

Fertilizer, Phosphate, Potash, Crop Nutrients, Agriculture, Mining, Earnings Report, Financial Results, Mosaic Company, MOS, Brazil, Canada, Cost Reduction, EBITDA, Supply Chain, Commodities